Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
ReShape Lifesciences Inc. (OBLN)
|
|
Operating Efficiency |
|
|
|
|
Annual |
|
In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Source | Source | Source | Source | Source | Source | Source | Source |
Turnover Ratios |
Inventory turnover | 2.0 | 2.4 | 1.7 | 3.6 | 4.3 | 4.7 | 6.2 | |
Asset turnover | 0.3 | 0.4 | 0.1 | 0.2 | 0.2 | 0.1 | 0.2 | |
|
Returns on Capital |
ROIC (excluding intangibles) | -107.5% | -84.3% | -772.1% | -264.6% | -230.5% | -352.3% | -153.0% | |
ROIC (including intangibles) | -109.5% | -47.1% | -758.7% | -1250.3% | -137.6% | -401.4% | -240.2% | -74.2% |
ROE | -60.1% | -85.3% | -146.7% | -282.1% | -98.0% | -30.3% | 3391.0% | -65.8% |
ROA | -51.1% | -33.3% | -114.0% | -121.7% | -64.8% | -24.8% | -104.9% | -47.6% |
|
Cash Conversion Cycle |
Days sales outstanding | 75.5 | 0.0 | 31.7 | 34.9 | 155.5 | 55.4 | 57.5 | 10.2 |
Days payables outstanding | 241.0 | 264.9 | 80.2 | 78.0 | 96.4 | 77.3 | | |
Days inventory outstanding | 208.7 | 162.6 | 239.5 | 106.3 | 107.2 | 107.5 | 52.9 | 55.8 |
Cash conversion cycle | 43.2 | -102.2 | 191.1 | 63.2 | 166.2 | 85.5 | 110.4 | 66.0 |
|